Japanese and South Korean companies are expected to lead a wave of acquisition activity out of the region this year ...

The Trading Radar highlights key earnings and economic announcements for tomorrow’s trading session: Before The Market Opens Earnings: Astronics Corp (Nasdaq: ATRO) - consensus EPS $0.40 Boardwalk Pipeline Partners (NYSE: BWP) - consensus EPS $0.41 Changyou.com Limited (Nasdaq: CYOU) - consensus EPS $1.09 ePlus, Inc. (Nasdaq: PLUS) - no Stree...

Here is a recap of the top news items from this week on Wall Street: 1. The Facebook IPO was an obvious #1 on the top ten……. until Friday’s blowout jobs report. 243,000 payrolls were added in the nonfarm sector, 257,000 were added in the private sector and, in the manufacturing sector, about 50,000 jobs were added. Economists were...

Gainers SPDR S&P 500 (NYSE: SPY) up 1.28 percent to $134.38. The S&P 500 and other U.S. markets up Friday following a smattering of positive economic data. Nonfarm payrolls at 243K, beating views of 140K; ISM Services Index at 56.8, versus 53.1 consensus; and Unemployment rate drops from 8.5 percent down to 8.3 percent. Markets are up we...

The following is a list of notable articles to help get you through the lunch hour: Kyle Bass: ‘Keep Your Gold’ (GLD) -> Read this! Gilead (GILD) Issues Strong ‘7977 Update, Shares Move Higher -> Read this! Firsthand Technology Value Fund (SVVC) Continues Parabolic Move On Facebook Hype, Shorts Licking Their Chops -> Rea...

Threshold Pharmaceuticals, Inc (Nasdaq: THLD) 86% HIGHER; today announced that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. TH-302 is currently being investigated in a global Phase 3 clinical trial in patients with soft tissue sarco...

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High: Gilead Sciences, Inc. (Nasdaq: GILD) high of $54.77. Gilead moving higher Friday following fourth-quarter numbers, but more importantly, an update to HCV treatment PSI-7977. On its conference call following results,...

UPGRADES BofA/Merrill Lynch upgrades Dendreon (Nasdaq: DNDN) from Underperform to Neutral. Morgan Stanley lifts National-Oilwell Varco (NYSE: NOV) from Equal Weight to Overweight with a price target of $100. Barclays raises BB&T Capital (NYSE: BBT) from Underweight to Equalweight, its price target raised from $32 to $34. Janney Montgomery Scott...

Threshold Pharmaceuticals, Inc (Nasdaq: THLD) 93% HIGHER; today announced that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. TH-302 is currently being investigated in a global Phase 3 clinical trial in patients with soft tissue sarco...

BB&T Corporation (NYSE: BBT) has reached an agreement to acquire the life and property and casualty insurance operating divisions of Roseland, N.J.,- based Crump Group Inc. Under the terms of the agreement, BB&T will acquire Crump Life Insurance Services and Crump Property & Casualty Insurance Services for $570 million in cash. The tra...